{"nct_id":"NCT05043090","title":"Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-05","start_date":"2021-10-28","start_date_type":"ACTUAL","primary_completion_date":"2025-06-23","primary_completion_date_type":"ESTIMATED","completion_date":"2025-10-30","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}